IMATINIB MESYLATE IN THE TREATMENT OF PAEDIATRIC CHRONIC MYELOID LEUKEMIA: A STUDY OF 55 PATIENTS FROM A TERTIARY CARE CANCER CENTRE IN PAKISTAN

被引：0
|
作者：
Rashid, Aqeela [1 ]
Maaz, Ata [2 ]
机构：
[1] Shaukat Khanum Hosp, Lahore, Pakistan
[2] Bristol Royal Hosp Children, Bristol, Avon, England
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1038 / 1038
页数：1
相关论文
共 50 条
  • [31] Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia
    Beyazit, Y
    Aksu, S
    Kekilli, M
    Haznedaroglu, IC
    Kilickap, S
    Goker, H
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (01) : 79 - 80
  • [32] Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate
    Xu, Y
    Wahner, AE
    Nguyen, PL
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2004, 128 (09) : 980 - 985
  • [33] Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia
    Machaczka, Maciej
    Gossart, Maria
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (05): : 251 - 252
  • [34] Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia
    Pou, M
    Saval, N
    Vera, M
    Saurina, A
    Solé, M
    Cervantes, F
    Botey, A
    LEUKEMIA & LYMPHOMA, 2003, 44 (07) : 1239 - 1241
  • [35] The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
    Oehler, Vivian G.
    Gooley, Ted
    Snyder, David S.
    Johnston, Laura
    Lin, Allen
    Cummings, Carrie C.
    Chu, Su
    Bhatia, Ravi
    Forman, Stephen J.
    Negrin, Robert S.
    Appelbaum, Frederick R.
    Radich, Jerald P.
    BLOOD, 2007, 109 (04) : 1782 - 1789
  • [36] Trisomy 8 finding treatment of imatinib mesylate in chronic myeloid leukemia cases
    Tunca, Y
    Güran, S
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (02) : 151 - 151
  • [37] Efficacy and tolerability of imatinib mesylate in pediatric chronic myeloid leukemia in a large cohort: Results from a tertiary care referral center in India
    Ghadyalpatil, N.
    Banawali, S.
    Kurkure, P.
    Arora, B.
    Bansal, S.
    Amare, P.
    Choughule, A.
    Soy, L.
    Singh, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Assessment of cardiotoxicity of imatinib mesylate in chronic myeloid leukemia patients - a cross-sectional study
    Marcolino, M. S.
    Bittencourt, H. N. S.
    Clementino, N. C. D.
    Barbosa, M. M.
    Nunes, M. C. P.
    Xavier, V. F.
    Ribeiro, A. L. P.
    CIRCULATION, 2008, 118 (12) : E412 - E412
  • [39] Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India.
    Ostwal, V.
    Ghadyalpatil, N.
    Prabhash, K.
    Menon, H.
    Nair, R.
    Sengar, M.
    Noronha, V.
    Biswas, S.
    Bhosale, B.
    Banavali, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
    Akay, Olga Meltem
    Mutlu, Fezan
    Gulbas, Zafer
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 127 - 130
12345